These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 3936696

  • 1. [Several critical aspects of the value of peripheral markers in depression (TRH test and dexamethasone depression)].
    Chabannes JP, Lambert PA, Rene-Aussedat H, Baro P, Torres JP.
    Encephale; 1985; 11(4):167-9. PubMed ID: 3936696
    [Abstract] [Full Text] [Related]

  • 2. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H, Kaufman L, De Weert D, Cornet C, Raets I.
    Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous use of thyrotropin-releasing hormone test and combined dexamethasone/corticotropine-releasing hormone test for severity evaluation and outcome prediction in patients with major depressive disorder.
    Isogawa K, Nagayama H, Tsutsumi T, Kiyota A, Akiyoshi J, Hieda K.
    J Psychiatr Res; 2005 Sep; 39(5):467-73. PubMed ID: 15992555
    [Abstract] [Full Text] [Related]

  • 4. Neuroendocrine abnormalities in affective disorders.
    Extein I, Pottash AL, Gold MS.
    Encephale; 1982 Sep; 8(2):203-11. PubMed ID: 6809445
    [Abstract] [Full Text] [Related]

  • 5. [Biologic diagnosis of depression by the TRH and dexamethasone tests].
    Chabrol H, Moron P.
    Encephale; 1983 Sep; 9(1):1-22. PubMed ID: 6135596
    [Abstract] [Full Text] [Related]

  • 6. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Weissenburger JE, Fulton CL, Fairchild CJ, Roffwarg HP.
    Biol Psychiatry; 1997 May 01; 41(9):915-28. PubMed ID: 9110097
    [Abstract] [Full Text] [Related]

  • 7. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment.
    Escobar JI, Halaris A, Baxter L, Schwarcz G, Thompson M, Hurwicz ML, Hill M, Young M, Daugherty K, Clemens A.
    Psychopharmacol Bull; 1985 May 01; 21(1):77-80. PubMed ID: 3920706
    [No Abstract] [Full Text] [Related]

  • 8. The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics.
    Dackis CA, Pottash AL, Bailey J, Stuckey RF, Extein IL, Gold MS.
    NIDA Res Monogr; 1983 Apr 01; 43():266-72. PubMed ID: 6410260
    [No Abstract] [Full Text] [Related]

  • 9. TRH stimulation and dexamethasone suppression in borderline personality disorder.
    De la Fuente JM, Mendlewicz J.
    Biol Psychiatry; 1996 Sep 01; 40(5):412-8. PubMed ID: 8874844
    [Abstract] [Full Text] [Related]

  • 10. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD.
    Biol Psychiatry; 1983 Jan 01; 18(1):3-19. PubMed ID: 6403062
    [Abstract] [Full Text] [Related]

  • 11. Effects of acute hospitalization on the dexamethasone suppression and TRH stimulation tests.
    Roy-Byrne P, Gwirtsman H, Sternbach H, Gerner RH.
    Biol Psychiatry; 1984 Apr 01; 19(4):607-12. PubMed ID: 6428471
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical use of the dexamethasone suppression test].
    De Leo D, Capodieci S.
    Minerva Psichiatr; 1984 Apr 01; 25(2):115-25. PubMed ID: 6436632
    [No Abstract] [Full Text] [Related]

  • 13. Biological markers of melancholia and reclassification of depressive disorders.
    Greden JF.
    Encephale; 1982 Apr 01; 8(2):193-202. PubMed ID: 6809444
    [Abstract] [Full Text] [Related]

  • 14. New trends in the diagnosis and treatment of depression.
    Taska R, Brodie HK.
    J Clin Psychiatry; 1983 May 01; 44(5 Pt 2):11-3. PubMed ID: 6406437
    [Abstract] [Full Text] [Related]

  • 15. [The TRH test in 60 depressed adolescents].
    Chabrol H, Sablayrolles B, Rochiccioli P, Moron P.
    Encephale; 1985 May 01; 11(5):209-10. PubMed ID: 3936697
    [Abstract] [Full Text] [Related]

  • 16. [Biological aspects of dysthymia].
    Poirier MF.
    Encephale; 1994 Jun 01; 20 Spec No 2():257-60. PubMed ID: 7916287
    [No Abstract] [Full Text] [Related]

  • 17. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD.
    Biol Psychiatry; 1984 Mar 01; 19(3):305-18. PubMed ID: 6426529
    [Abstract] [Full Text] [Related]

  • 18. [Study of the evolution of some monocytic parameters and neuroendocrine function tests in depressed patients].
    Cervera Enguix S, Rodríguez-Rosado A, Ramos Ruiz F, Sarrais Oteo F, Pla Vidal J, Rodríguez-Rosado R.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995 Mar 01; 23(2):67-73. PubMed ID: 7625239
    [Abstract] [Full Text] [Related]

  • 19. Neuroendocrine predictors of the antidepressant effect of partial sleep deprivation.
    Joffe R, Brown P, Bienenstock A, Mitton J.
    Biol Psychiatry; 1984 Mar 01; 19(3):347-52. PubMed ID: 6426532
    [Abstract] [Full Text] [Related]

  • 20. Depression and endocrine disorders: focus on the thyroid and adrenal system.
    Musselman DL, Nemeroff CB.
    Br J Psychiatry Suppl; 1996 Jun 01; (30):123-8. PubMed ID: 8864158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.